Summary
There is an overwhelming consensus on the fact thatStreptococcus pneumoniae, Haemophilus influenzae andMoraxella catarrhalis represent the prevailing bacterial pathogens of community-acquired lower respiratory tract infections. Their specific incidence as causative agents of the more common syndromes is known to vary even profoundly depending on geographic location, and the same holds true for the rates of resistance to antimicrobial drugs. Europe does not escape the threat posed by the present pandemic spread of penicillin resistance inS. pneumoniae although, as expected, countries like Spain and France are greatly affected, while others including Germany, Italy, The Netherlands and the Scandinavian region are comparatively spared. In several sites multiple resistance has been described inS. pneumoniae and the most affected drugs include penicillin, the macrolides, co-trimoxazole and tetracycline. InH. influenzae synthesis of β-lactamases the main trait of resistance is expressed. Lack of susceptibility to β-lactams dictated by a different mechanism remains extremely rare. Considerable variations in the incidence of this characteristic are apparent when European countries are considered. France and Spain are again widely affected, while Germany, The Netherlands and Italy display rates of β-lactamase-positiveH. influenzae of about 10%.M. catarrhalis must be considered generally resistant to non-protected aminopenicillins since over 90% of these organisms produce β-lactamases.
Similar content being viewed by others
References
Bisno, A. L., Gerber, M. A., Gwaltney, J. M. Jr., Kaplan, E. L., Schwartz, R. H.: Diagnosis and management of group A streptococcal pharyngitis: a practical guideline. Clin. Infect. Dis. 25 (1997) 574–583.
Bartlett, J. G., Breiman, R. F., Mandell, L. A.: Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26 (1998) 811–838.
Eskola, J., Hovi, T.: Respiratory viruses in acute otitis media. N. Engl. J. Med. 342 (1999) 312–313.
Austrian, R.: The enduring pneumococcus: unfinished business and opportunities for the future. Microbiol. Drug Res. 3 (1997) 111–115.
Tomasz, A.: Antibiotic resistance inStreptococcus pneumoniae. Clin. Infect. Dis. 24 (Suppl. 1) (1997) S85–88.
Kaplan, S. L., Manson, E. O. Jr.: Management of infections due to antibiotic-resistantStreptococcus pneumoniae. Clin. Microbiol. Rev. 11 (1998) 628–644.
Craig, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26 (1998) 1–12.
Felmingham, D., Gruneberg, R. N. andThe Alexander Project Group: A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992–1993: The Alexander Project. J. Antimicrob. Chemother. 30 (Suppl. A) (1996) 1–57.
Goldstein, F. W., Bryskier, A., Appelbaum, P. C., Bauernfeind, A., Jacobs, M., Schito, G. C., Wise, R.: The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory tract pathogens. Clin. Microbiol. Infect. 4 (Suppl. 2) (1998) S8–18.
Magliano, E. M., Osservatorio Epidemiologico Italiano: Introduzione, metodi e scopo della ricerca. GIMMOC 2 (1998) 7–14.
Schito, G. C., Mannelli, S., Debbia, E. A., Pesce, A., Marchese, A., Osservatorio Epidemiologico Italiano: Analisi del primo anno di monitoraggio delle resistenze agli antibiotici inStreptococcus pneumoniae: GIMMOC 2 (1998) 15–27.
Schito, G. C., Mannelli, S., Cibrario-Sent, M., Pesce, A., Marchese, A.: Evoluzione della eesistenze ai farmaci antibiomicrobici inStreptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano. GIMMOC 3 (1999) 43–57.
Dagan, R., Leibovitz, E., Greenberg, D., Yagupsky, P., Fliss, D., Leiberman, A.: Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Ped. Infect. Dis. J. 17 (1998) 776–782.
Mazzaglia, G., Greco, S., Lando, C., Cucinotta, G., Caputi, A. P.: Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. J. Antimicrob. Chemother. 41 (1998) 256–266.
Marchese, A., Ramirez, M., Schito, G. C., Tomasz, A.: Molecular epidemiology of penicillin-resistantStreptococcus pneumoniae isolated in Italy during 1993–1996. J. Clin. Microbiol. 36 (1998) 2944–2949.
Marchese A., Tonoli, E., Debbia, E. A., Schito, G. C.: Macrolide resistance mechanisms and expression of phenotypes amongStreptococcus pneumoniae circulating in Italy. J. Antimicrob. Chemother. (in press 1999).
Johnston, N. J., de Azavedo, J. C., Kellner, J. D., Low, D. E.: Prevalence and characterization of the mechanism of macrolide, lincosamide, and streptogramin resistance in isolates ofStreptococcus pneumoniae. Antimicrob. Agents Chemother. 42 (1998) 2425–2426.
Sutcliffe, J., Tait-kamradt, A., Wondrack, L.:Streptococcus pneumoniae andStreptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40 (1996) 1817–1824.
McDougal, L. K., Tenover, F. C.: Characterisation of macrolide resistance phenotypes inStreptococcus pneumoniae. In: Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstr. C-77b, p. 59. American Society for Microbiology, Washington DC., 1997.
Nicoletti, G., Aleo, G., Blandino, G., Russo, R., Speciale, A., Valenti, D., Caccamo, F.: Osservatorio epidemiologico italiano: analisis del 2° anno di monitoraggio delle resistenze agli antibiotici inH. influenzae eH. parainfluenzae. GIMMOC 3 (1999) 58–69.
Nicoletti, G., Speciale, A., Aleo, G., Blandino, G., Russo, R., Caccamo, F.: Osservatorio epidemiologico italiano: analisi del 2° anno di monitoraggio delle resistenze agli antibiotici inM. catarrhalis. GIMMOC 3 (1999) 70–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Debbia, E.A., Shito, G.C., Pesce, A. et al. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. Infection 27 (Suppl 2), S9–S12 (1999). https://doi.org/10.1007/BF02561662
Issue Date:
DOI: https://doi.org/10.1007/BF02561662